Laman UtamaORX • STO
add
Orexo AB
Tutup sebelumnya
kr 24.50
Julat hari
kr 23.40 - kr 25.20
Julat tahun
kr 12.50 - kr 43.40
Permodalan pasaran
867.77J SEK
Bilangan Purata
35.64K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
STO
Berita pasaran
The Globe and Mail
14 jam lalu
PesoRama Secures TSXV Approval for Equity Financing with Clarifications
1.96%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (SEK) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 118.70J | -13.04% |
Perbelanjaan pengendalian | 132.51J | -2.13% |
Pendapatan bersih | -29.80J | 28.88% |
Margin untung bersih | -25.11 | 18.21% |
Pendapatan bagi setiap syer | — | — |
EBITDA | -9.61J | -580.50% |
Kadar cukai berkesan | 8.87% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (SEK) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 105.60J | -8.09% |
Jumlah aset | 518.60J | -25.60% |
Jumlah liabiliti | 742.90J | 2.58% |
Jumlah ekuiti | -224.30J | — |
Syer tertunggak | 34.71J | — |
Harga kepada buku | -3.79 | — |
Pulangan pada aset | -9.94% | — |
Pulangan pada modal | -18.48% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (SEK) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -29.80J | 28.88% |
Tunai daripada operasi | -10.30J | 23.13% |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | -4.60J | 22.03% |
Perubahan bersih dalam tunai | -15.70J | 36.69% |
Aliran tunai bebas | -8.13J | -166.92% |
Perihal
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Diasaskan
1995
Tapak web
Pekerja
104
